|
FOXN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.848200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33799999999063E-05 |
| Normal-vs-Stage2 |
3.307800E-01 |
| Normal-vs-Stage3 |
3.173800E-01 |
| Normal-vs-Stage4 |
8.552800E-01 |
| Stage1-vs-Stage2 |
8.506000E-02 |
| Stage1-vs-Stage3 |
5.092400E-02 |
| Stage1-vs-Stage4 |
2.438000E-01 |
| Stage2-vs-Stage3 |
9.866400E-01 |
| Stage2-vs-Stage4 |
7.140600E-01 |
| Stage3-vs-Stage4 |
7.183600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.80910000000024E-05 |
| Normal-vs-AfricanAmerican |
8.184800E-03 |
| Normal-vs-Asian |
9.342000E-01 |
| Caucasian-vs-AfricanAmerican |
5.243000E-01 |
| Caucasian-vs-Asian |
1.899230E-01 |
| AfricanAmerican-vs-Asian |
3.216800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5752899999999E-05 |
| Normal-vs-Female |
4.424600E-01 |
| Male-vs-Female |
2.456400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.201400E-03 |
| Normal-vs-Extreme_Weight |
2.04169999999948E-05 |
| Normal-vs-Obese |
7.339700E-02 |
| Normal-vs-Extreme_Obese |
3.410600E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.734600E-01 |
| Normal_Weight-vs-Obese |
2.367000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.818600E-01 |
| Extreme_Weight-vs-Obese |
2.409600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.176800E-01 |
| Obese-vs-Extreme_Obese |
1.300240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.848000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.436000E-02 |
| Normal-vs-Age(61-80Yrs) |
8.58259999958477E-07 |
| Normal-vs-Age(81-100Yrs) |
8.17350000000827E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.824300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.084200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.036000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.141850E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.678300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.946600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.043260E-04 |
| Normal-VS-Type2 PRCC |
2.242300E-04 |
| Normal-VS-KIRP CIMP |
1.126400E-02 |
| Normal-VS-Unclassified PRCC |
3.250000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.727200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.47689971363718E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
5.292100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.01589999979402E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
5.788200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.567200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.60169999999993E-05 |
| Normal-vs-N1 |
4.436400E-01 |
| Normal-vs-N2 |
1.466360E-01 |
| N0-vs-N1 |
5.478600E-03 |
| N0-vs-N2 |
6.043600E-01 |
| N1-vs-N2 |
3.336600E-01 |
|
|
